IP vs NERV · P/E 43, $26.62B cap vs P/E 2.2, $12.4M cap
International Paper (IP) versus Minerva Neurosciences Inc (NERV) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Minerva Neurosciences Inc (NERV) is a biotechnology company listed on US.
IP does not have a complete income-statement cache yet.
Latest reported NERV revenue for 2024-12-31 was $0. Net income was $1.4M. NERV currently screens at market cap $12.4M and trailing P/E 2.2.
IP currently screens at market cap $26.62B and trailing P/E 43.1. NERV currently screens at market cap $12.4M and trailing P/E 2.2.
Not investment advice. Open the IP and NERV stock pages for the full models.
Not investment advice.